Piper Sandler Upgrades Steris to Overweight, Raises Price Target to $260
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler has upgraded Steris (NYSE:STE) from Neutral to Overweight and increased the price target from $230 to $260, indicating a positive outlook for the company's stock.
October 24, 2024 | 1:54 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Piper Sandler has upgraded Steris from Neutral to Overweight and raised the price target to $260, suggesting a positive short-term outlook for the stock.
The upgrade from Neutral to Overweight by Piper Sandler indicates increased confidence in Steris's performance. The raised price target from $230 to $260 suggests potential upside, likely leading to positive investor sentiment and a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100